Proteomics

Dataset Information

0

Phosphoproteome analysis from BCR-ABL, MYC and CD22DE12 transgenic mouse models

ABSTRACT: Leukemic splenocytes from these commercial transgenic mice that developed fatal leukemia with massive splenomegaly were isolated at the time of the necropsy and subjected to gene expression profiling and phosphoprotein profiling in side by side comparison with CD22DE12-Tg BPL or CD22DE12_BCR-ABL double transgenic cells.

ORGANISM(S): Mus musculus Rattus norvegicus Homo sapiens

PROVIDER: GSE58873 | GEO | 2015/06/25

SECONDARY ACCESSION(S): PRJNA253778

REPOSITORIES: GEO

Json Xml

Similar Datasets

Transcriptomics mRNA expression data from BCR-ABL, MYC and CD22DE12 transgenic mouse models
2015-06-25 | GSE58872 | GEO
Transcriptomics mRNA expression data from BCR-ABL, MYC and CD22DE12 transgenic mouse models
2015-06-25 | E-GEOD-58872 | biostudies-arrayexpress
Unknown Integrative phosphoproteome and interactome analysis of the role of Ubash3b in BCR-ABL signaling.
| S-EPMC6934410 | biostudies-literature
Unknown Targeting BCR-ABL+ stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex.
| S-EPMC5546432 | biostudies-literature
Unknown Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells.
| S-EPMC8758722 | biostudies-literature
Unknown Exon-skipping in BCR/ABL is induced by ABL exon 2.
| S-EPMC1221036 | biostudies-other
Unknown The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR/ABL proteins.
| S-EPMC5352360 | biostudies-literature
Transcriptomics CEA_SGF:E00010#bcr-abl
2005-05-01 | GSE1429 | GEO
Unknown BCR-ABL affects STAT5A and STAT5B differentially.
| S-EPMC4023949 | biostudies-literature
Transcriptomics HGAL Enhances BCR-mediated Syk Activation, Leading to Lymphoid Hyperplasia and Amyloidosis
2013-05-22 | E-GEOD-35400 | biostudies-arrayexpress